GILD
Gilead Sciences, Inc.
Healthcare
$130.50
as of May 21, 2026
Sign in to add GILD to your portfolio.
Sign inMarket cap
$162.26B
P/E (TTM)
17.6x
EPS (TTM)
$7.42
Dividend yield
2.44%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $27.30B | $6.22B | $10.80B | 75.8% | 36.3% | $4.96 |
| 2022 | $27.28B | $4.59B | $8.34B | 79.3% | 26.9% | $3.66 |
| 2023 | $27.12B | $5.67B | $7.42B | 76.0% | 28.0% | $4.54 |
| 2024 | $28.75B | $480.00M | $10.30B | 78.3% | 5.8% | $0.38 |
| 2025 | $29.44B | $8.51B | $9.46B | 78.8% | 39.7% | $6.84 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $130.01 | $130.50 | 4.72M |
| May 20, 2026 | $131.36 | $130.69 | 5.57M |
| May 19, 2026 | $129.50 | $130.50 | 5.01M |
| May 18, 2026 | $130.15 | $129.67 | 5.18M |
| May 15, 2026 | $132.27 | $129.58 | 6.64M |
| May 14, 2026 | $133.77 | $132.06 | 4.53M |
| May 13, 2026 | $133.55 | $133.05 | 6.67M |
| May 12, 2026 | $135.00 | $134.94 | 6.03M |
| May 11, 2026 | $131.01 | $133.52 | 5.38M |
| May 08, 2026 | $130.00 | $131.33 | 10.25M |
| May 07, 2026 | $136.50 | $134.06 | 8.90M |
| May 06, 2026 | $133.38 | $136.30 | 6.35M |
| May 05, 2026 | $132.84 | $133.48 | 6.15M |
| May 04, 2026 | $130.44 | $132.69 | 5.88M |
| May 01, 2026 | $130.00 | $131.65 | 5.52M |
| Apr 30, 2026 | $127.96 | $130.84 | 6.66M |
| Apr 29, 2026 | $128.90 | $128.84 | 5.05M |
| Apr 28, 2026 | $130.33 | $129.26 | 5.94M |
| Apr 27, 2026 | $128.80 | $127.75 | 8.17M |
| Apr 24, 2026 | $131.54 | $130.40 | 5.97M |
| Apr 23, 2026 | $134.02 | $133.64 | 3.87M |
| Apr 22, 2026 | $133.69 | $132.90 | 6.70M |
| Apr 21, 2026 | $136.18 | $133.29 | 6.07M |
| Apr 20, 2026 | $138.06 | $135.87 | 3.87M |
Profitability & balance
- ROE (TTM)
- 42.2%
- Gross margin
- 79.3%
- Operating margin
- 38.3%
- Net margin
- 31.0%
- Debt / equity
- 0.94